ARK Genomic Revolution ETF vs HSBC Holdings plc — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while HSBC Holdings plc trades at $104.04 (market cap $353.82B). The key difference: HSBC Holdings plc pays a 3.63% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | HSBC | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $107.86 |
52-Week Low | $24.02 | $63.84 |
Market Cap | — | $353.82B |
Dividend Yield | — | 3.63% |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →